サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1563919

セルソーティングの世界市場

Cell Sorting

出版日
ページ情報
英文 184 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
セルソーティングの世界市場
出版日: 2024年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

セルソーティングの世界市場は2030年までに16億米ドルに達する見込み

2023年に8億6,920万米ドルと推定されるセルソーティングの世界市場は、分析期間2023-2030年にCAGR 9.2%で成長し、2030年には16億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるセルソーター・コンポーネントは、CAGR 9.9%を記録し、分析期間終了時には8億6,200万米ドルに達すると予測されます。試薬・消耗品セグメントの成長率は、分析期間中CAGR 9.1％と推定されます。

米国市場は推定2億4,110万米ドル、中国はCAGR8.5％で成長予測

米国のセルソーティング市場は、2023年に2億4,110万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR 8.5%を牽引し、2030年までに2億4,390万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.6%と7.3%と予測されています。欧州では、ドイツがCAGR 7.3%で成長すると予測されています。

世界のセルソーティング市場- 主要動向と促進要因のまとめ

セルソーティングはどのように生物医学調査と臨床応用に革命を起こしているのか？

セルソーティングは、バイオメディカル研究と臨床応用の両方において重要な技術であり、科学者や臨床医がそのユニークな特徴に基づいて、異種混合物から特定の細胞集団を分離することを可能にします。このプロセスは、細胞生物学、疾病メカニズム、治療法開発の理解を深めるために不可欠です。Fluorescence-Activatedセルソーティング（FACS）やMagnetic-Activatedセルソーティング（MACS）などのセルソーティングテクノロジーは、細胞のサイズ、形態、タンパク質発現、蛍光マーカーに基づいて細胞を分離することを可能にし、特定の細胞タイプの正確な分析を可能にしました。調査において、セルソーティングは免疫学、腫瘍学、幹細胞生物学などの分野で重要な役割を果たしています。例えば、感染症や治療に対する免疫細胞の挙動を研究するために免疫細胞を分離したり、腫瘍の進行や薬剤耐性をよりよく理解するために遺伝子プロファイリングのためにがん細胞を選別したりすることができます。臨床応用では、セルソーティングは骨髄移植のような処置や、有効性と安全性を確保するために治療細胞の純粋な集団を分離しなければならない細胞ベースの治療法の製造に不可欠です。セルソーティングの技術が進歩するにつれて、基礎科学と治療革新の両方において画期的な進歩を遂げ続けています。

なぜセルソーティングが細胞ベースの治療法の開発に不可欠なのか？

セルソーティングは、特に免疫療法や再生医療などの細胞ベースの治療法の開発に不可欠です。CAR-T細胞治療のような治療では、免疫細胞が患者の血液から抽出され、がん細胞を標的とするように遺伝子改変され、拡大された後、患者に再注入されます。この治療が成功するかどうかは、T細胞を正確に選別・分離し、腫瘍を標的にできる細胞だけを確実に使用できるかどうかにかかっています。同様に幹細胞治療では、骨髄などの組織から幹細胞集団を精製するためにソーティング技術が使われます。高度なソーティング技術によって高純度で生存可能な細胞集団を確保することは、これらの治療の安全性と有効性にとって極めて重要です。治療開発における役割にとどまらず、セルソーティングテクノロジーは、特定の免疫細胞や腫瘍細胞を分離して分析することにより、治療に対する患者の反応をモニターするためにも使用されています。この機能は、治療計画を最適化し、治療成績を向上させるための鍵となるもので、セルソーティングは個別化医療の進歩に不可欠なツールとなっています。

技術革新はどのようにセルソーティング技術を向上させているか？

技術の進歩は、セルソーティング技術の精度、スピード、スケーラビリティを劇的に向上させ、研究および臨床応用の両方においてより効果的なものにしています。この分野における最も重要な技術革新の一つは、最小限の人的介入で大量のサンプルを処理できるハイスループットの自動選別システムの開発です。このようなシステムは、医薬品開発や患者の診断を進めるために大量の細胞サンプルを迅速に分析し、ソーティングする必要がある、製薬研究や臨床試験において特に有用です。マイクロ流体ベースのソーティング技術もこの分野に革命をもたらしており、高度に小型化された環境で個々の細胞を正確にコントロールすることができます。このアプローチは、ソーティング過程における細胞へのダメージを最小限に抑え、ソーティングされた集団の純度と生存率を向上させる。これは、幹細胞治療やがん治療のような繊細なアプリケーションにおいて特に重要です。誘電泳動や音響波に基づくようなラベルフリーのセルソーティング技術は、蛍光標識や磁気標識に依存する従来の方法に代わる強力な方法として台頭してきています。これらの新技術は細胞の完全性を保持し、より正確な下流分析を可能にします。さらに、人工知能と機械学習の進歩がソーティング・プラットフォームに統合され、ソーティング・プロセス中の意思決定を最適化することで、標的細胞のより効率的な分離とエラーの減少につながっています。

セルソーティング市場の主な成長促進要因は？

セルソーティング市場の成長は、細胞ベースの治療に対する需要の高まり、バイオテクノロジーの進歩、研究および臨床の両方における高精度細胞分析のニーズの高まりなど、いくつかの要因によってもたらされます。特にCAR-T細胞療法の開発では、遺伝子組み換えや治療用に特定の免疫細胞を分離する必要があります。より多くの細胞ベース療法が臨床に入るにつれ、信頼性が高く拡張性のあるセルソーティング技術へのニーズは高まり続けています。自動化されたマイクロ流体ベースのソーティングシステムなどの技術革新は、セルソーティングをあらゆる規模のラボにとってより利用しやすく効率的にすることで、市場の成長をさらに促進しています。さらに、個別化医療への注目の高まりがセルソーティングの需要を後押ししています。セルソーティングを使えば、患者固有の細胞を分離・分析できるため、個々の細胞プロファイルに基づいた標的治療の開発が可能になるからです。また、詳細な分子研究のために個々の細胞を選別・分離する必要があるシングルセル解析の台頭も、セルソーティング市場の成長に寄与しています。さらに、がんや自己免疫疾患などの慢性疾患の蔓延が拡大しているため、新しい診断法や治療法の開発をサポートする高度なセルソーティング技術に対する需要が高まっています。ライフサイエンス研究への継続的な投資と調査技術の進歩により、セルソーティング市場は今後数年で力強い成長を遂げることが予想されます。

調査対象企業の例（全21件）

  • Affymetrix, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cytonome/St, LLC
  • Miltenyi Biotec GmbH
  • On-Chip Biotechnologies Co., Ltd.
  • Sony Biotechnology Inc.
  • Sysmex Partec GmbH
  • Union Biometrica, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10951

Global Cell Sorting Market to Reach US$1.6 Billion by 2030

The global market for Cell Sorting estimated at US$869.2 Million in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2023-2030. Cell Sorters Component, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$862.0 Million by the end of the analysis period. Growth in the Reagents & Consumables Component segment is estimated at 9.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$241.1 Million While China is Forecast to Grow at 8.5% CAGR

The Cell Sorting market in the U.S. is estimated at US$241.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$243.9 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.6% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.

Global Cell Sorting Market - Key Trends and Drivers Summarized

How Is Cell Sorting Revolutionizing Biomedical Research and Clinical Applications?

Cell sorting is a critical technique in both biomedical research and clinical applications, allowing scientists and clinicians to separate specific cell populations from heterogeneous mixtures based on their unique characteristics. This process is essential for advancing our understanding of cellular biology, disease mechanisms, and therapeutic development. Cell sorting technologies, such as Fluorescence-Activated Cell Sorting (FACS) and Magnetic-Activated Cell Sorting (MACS), have made it possible to isolate cells based on size, morphology, protein expression, or fluorescent markers, enabling precise analysis of specific cell types. In research, cell sorting plays a crucial role in fields like immunology, oncology, and stem cell biology. For instance, it allows scientists to isolate immune cells to study their behavior in response to infection or therapy, or to sort cancer cells for genetic profiling to better understand tumor progression and drug resistance. In clinical applications, cell sorting is indispensable in procedures like bone marrow transplants and in the manufacturing of cell-based therapies, where pure populations of therapeutic cells must be isolated to ensure effectiveness and safety. As cell sorting technologies advance, they continue to drive breakthroughs in both basic science and therapeutic innovation.

Why Is Cell Sorting Essential for the Development of Cell-Based Therapies?

Cell sorting is integral to the development of cell-based therapies, particularly in areas such as immunotherapy and regenerative medicine. In therapies like CAR-T cell treatment, immune cells are extracted from a patient’s blood, genetically modified to target cancer cells, expanded, and then reinfused into the patient. The success of this therapy depends on the precise sorting and isolation of T cells, ensuring that only the cells capable of targeting tumors are used. Similarly, in stem cell therapies, sorting technologies are used to purify stem cell populations from tissues such as bone marrow, which can then be used to regenerate damaged tissues or treat degenerative diseases. Ensuring high-purity, viable cell populations through advanced sorting techniques is critical for the safety and efficacy of these therapies, as contamination with unwanted cell types can lead to adverse reactions or ineffective treatment. Beyond their role in treatment development, cell sorting technologies are also used to monitor patient responses to therapies by isolating specific immune or tumor cells for analysis. This capability is key for optimizing treatment plans and improving therapeutic outcomes, making cell sorting an essential tool in the advancement of personalized medicine.

How Are Technological Innovations Enhancing Cell Sorting Techniques?

Technological advancements are dramatically improving the accuracy, speed, and scalability of cell sorting techniques, making them more effective for both research and clinical applications. One of the most significant innovations in this space is the development of high-throughput, automated sorting systems that can process large sample volumes with minimal human intervention. These systems are particularly useful in pharmaceutical research and clinical trials, where large numbers of cell samples need to be analyzed and sorted quickly to advance drug development or patient diagnostics. Microfluidic-based sorting technologies are also revolutionizing the field, offering precise control over individual cells in a highly miniaturized environment. This approach minimizes the damage to cells during the sorting process and improves the purity and viability of the sorted populations, which is especially important in sensitive applications like stem cell therapy and cancer treatment. Label-free cell sorting techniques, such as those based on dielectrophoresis or acoustic waves, are emerging as powerful alternatives to traditional methods that rely on fluorescent or magnetic labeling. These new technologies preserve cell integrity, enabling more accurate downstream analyses. Furthermore, advances in artificial intelligence and machine learning are being integrated into sorting platforms to optimize decision-making during the sorting process, leading to more efficient isolation of target cells and reducing errors.

What Are the Key Growth Drivers in the Cell Sorting Market?

The growth in the cell sorting market is driven by several factors, including the rising demand for cell-based therapies, advancements in biotechnology, and the increasing need for high-precision cell analysis in both research and clinical settings. One of the primary drivers is the expanding use of cell sorting in immunotherapy, particularly in the development of CAR-T cell therapies, which require the isolation of specific immune cells for genetic modification and therapeutic use. As more cell-based therapies enter clinical practice, the need for reliable and scalable cell sorting technologies continues to grow. Technological innovations, such as automated and microfluidic-based sorting systems, are further propelling market growth by making cell sorting more accessible and efficient for laboratories of all sizes. Additionally, the increasing focus on personalized medicine is fueling demand for cell sorting, as it allows for the isolation and analysis of patient-specific cells, enabling the development of targeted treatments based on individual cellular profiles. The rise of single-cell analysis, which requires the sorting and isolation of individual cells for detailed molecular studies, is also contributing to the growth of the cell sorting market. Furthermore, the growing prevalence of chronic diseases, such as cancer and autoimmune disorders, is driving demand for advanced cell sorting technologies that can support the development of new diagnostics and treatments. With continued investment in life sciences research and the advancement of sorting technologies, the cell sorting market is expected to experience robust growth in the coming years.

Select Competitors (Total 21 Featured) -

  • Affymetrix, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cytonome/St, LLC
  • Miltenyi Biotec GmbH
  • On-Chip Biotechnologies Co., Ltd.
  • Sony Biotechnology Inc.
  • Sysmex Partec GmbH
  • Union Biometrica, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cell Sorting - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Medicine Expands Market for Cell Sorting Technologies
    • Advancements in Microfluidics Propel Growth in Automated Cell Sorting
    • Increasing Use of Fluorescence-Activated Cell Sorting (FACS) Drives Adoption in Research and Therapeutics
    • Growing Focus on Single-Cell Genomics Strengthens Demand for High-Precision Cell Sorting
    • Technological Innovations in Label-Free Sorting Methods Create New Opportunities in Cell Sorting
    • Expansion of Immunotherapy Boosts Demand for Efficient Cell Sorting Solutions
    • Rising Investment in Stem Cell Research Propels Growth in Cell Sorting Applications
    • Increased Focus on Rare Cell Populations Drives Innovation in Cell Sorting Techniques
    • Growing Use of Cell Sorting in Biopharmaceutical Production Fuels Market Expansion
    • Advances in Magnetic-Activated Cell Sorting (MACS) Enhance Efficiency in Cell Isolation and Sorting
    • Automation and High-Throughput Sorting Systems Boost Efficiency in Research and Clinical Workflows
    • Increased Use of Cell Sorting in Drug Discovery Expands Market for Innovative Sorting Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Sorting Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Sorting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cell Sorting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cell Sorting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cell Sorters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cell Sorters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Cell Sorters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Fluorescence-based Droplet Cell Sorting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Fluorescence-based Droplet Cell Sorting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Fluorescence-based Droplet Cell Sorting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Magnetic-activated Cell Sorting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Magnetic-activated Cell Sorting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Magnetic-activated Cell Sorting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for MEMS-Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for MEMS-Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for MEMS-Microfluidics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Research Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Medical Schools & Academic Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Medical Schools & Academic Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Medical Schools & Academic Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals & Clinical Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals & Clinical Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Hospitals & Clinical Testing Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • JAPAN
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • CHINA
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • EUROPE
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Cell Sorting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Cell Sorting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Cell Sorting by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • FRANCE
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • GERMANY
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030

IV. COMPETITION